Search company, investor...

Executives

51

Board of Directors

4

Ciox Health Management Team

51 Team Members

Ciox Health has 51 executives. Ciox Health's founder is Florian Quarré. Ciox Health's is .

Name

Work History

Title

Status

Florian Quarré

Founder

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Name

Florian Quarré

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Work History

Title

Founder

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

You're one click away from the most comprehensive, unmatched analyst expertise in tech, in-depth private company data and a platform that brings it all together.
Click Now. Join a live demo
Join a demo
CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo

Ciox Health Board of Directors

4 Board of directors

Ciox Health has 4 board of directors, including Clark Golestani.

Name

Firm

Work History

Other Seats

Clark Golestani

Clark Golestani has over 30 years of experience in health, life sciences and technology, and is an active investor, advisor and board member with a focus on the healthcare and technology, media, and telecommunications (TMT) sectors. Mr. Golestani currently serves as the managing director of C Sensei Group, LLC (csenseigroup.com) an advisory services firm; as a senior advisor to New Mountain Capital (newmountaincapital.com) based in New York City; as an investment advisor to both the K2 Access Fund (k2access.fund) based in Dover, DE, and The CXO Fund (thecxofund.com) based in San Jose, CA; and as Co-Chair of the DIA – Science and Policy Advisory Council (diaglobal.org). Mr. Golestani serves as an independent director on the board of directors for eMids (emids.com), Molecula (molecula.com), TruU, Inc. (truu.io), ToposWare, Inc. (toposware.com) and Zapata Computing (zapatacomputing.com). Mr. Golestani retired from Merck (merck.com) as the President, Emerging Businesses and Global CIO, with responsibilities for Merck’s portfolio of digital health services and solutions companies inclusive of the company's venture and equity funds – each of which extensively leverages opportunities across the digital health ecosystem. Further, Mr. Golestani led the company's global Information Technology organization, strategy, and execution worldwide, spanning all lines of business inclusive of Human Health and Animal Health BioPharma. Prior to joining Merck, Mr. Golestani was responsible for establishing and managing strategic client relationships from business development through consulting services engagement delivery as a principal with Oracle (oracle.com). Previously, Mr. Golestani served as chairman of the board for Sparta Systems (acquired by Honeywell); and on the Board of Directors for Ciox Health (merged with Datavant), Liaison Technologies (acquired by OpenText), Seal Software (acquired by DocuSign), NPower (npower.org), and UMUC/Ventures (umucventures.org). He has a degree in Management Science from Massachusetts Institute of Technology Sloan School of Management, and is a cofounder of Cross Road Technologies, Inc., in Cambridge, Massachusetts.

Ciox Health

Ed Coleman

Ciox Health, and Ciox Health

Jeffrey Hammerbacher

Jeff Hammerbacher is a scientist, software developer, entrepreneur, and investor. Jeff has founded and led teams that have produced dozens of scientific publications with hundreds of citations per year, 3 of the world's most popular open source database systems, over 100 angel investments, and a public company with a market capitalization of several billion dollars. Prior to founding Related Sciences, Jeff was the Principal Investigator of Hammer Lab, a founder and the Chief Scientist of Cloudera, an Entrepreneur-in-Residence at Accel, the manager of the Data team at Facebook, and a quant at Bear Stearns. In addition to his work at Related Sciences, Jeff is an angel investor with Techammer and is a board member at Ciox and Cytel. Jeff has a bachelor's degree in Mathematics from Harvard University.

Ciox Health

Jim Lacy

Experienced product focused software executive working with high-growth enterprises to deliver complex and mission critical solutions that provide high-impact to individuals and organizations.

Ciox Health

Name

Clark Golestani

Ed Coleman

Jeffrey Hammerbacher

Jim Lacy

Firm

Work History

Clark Golestani has over 30 years of experience in health, life sciences and technology, and is an active investor, advisor and board member with a focus on the healthcare and technology, media, and telecommunications (TMT) sectors. Mr. Golestani currently serves as the managing director of C Sensei Group, LLC (csenseigroup.com) an advisory services firm; as a senior advisor to New Mountain Capital (newmountaincapital.com) based in New York City; as an investment advisor to both the K2 Access Fund (k2access.fund) based in Dover, DE, and The CXO Fund (thecxofund.com) based in San Jose, CA; and as Co-Chair of the DIA – Science and Policy Advisory Council (diaglobal.org). Mr. Golestani serves as an independent director on the board of directors for eMids (emids.com), Molecula (molecula.com), TruU, Inc. (truu.io), ToposWare, Inc. (toposware.com) and Zapata Computing (zapatacomputing.com). Mr. Golestani retired from Merck (merck.com) as the President, Emerging Businesses and Global CIO, with responsibilities for Merck’s portfolio of digital health services and solutions companies inclusive of the company's venture and equity funds – each of which extensively leverages opportunities across the digital health ecosystem. Further, Mr. Golestani led the company's global Information Technology organization, strategy, and execution worldwide, spanning all lines of business inclusive of Human Health and Animal Health BioPharma. Prior to joining Merck, Mr. Golestani was responsible for establishing and managing strategic client relationships from business development through consulting services engagement delivery as a principal with Oracle (oracle.com). Previously, Mr. Golestani served as chairman of the board for Sparta Systems (acquired by Honeywell); and on the Board of Directors for Ciox Health (merged with Datavant), Liaison Technologies (acquired by OpenText), Seal Software (acquired by DocuSign), NPower (npower.org), and UMUC/Ventures (umucventures.org). He has a degree in Management Science from Massachusetts Institute of Technology Sloan School of Management, and is a cofounder of Cross Road Technologies, Inc., in Cambridge, Massachusetts.

Jeff Hammerbacher is a scientist, software developer, entrepreneur, and investor. Jeff has founded and led teams that have produced dozens of scientific publications with hundreds of citations per year, 3 of the world's most popular open source database systems, over 100 angel investments, and a public company with a market capitalization of several billion dollars. Prior to founding Related Sciences, Jeff was the Principal Investigator of Hammer Lab, a founder and the Chief Scientist of Cloudera, an Entrepreneur-in-Residence at Accel, the manager of the Data team at Facebook, and a quant at Bear Stearns. In addition to his work at Related Sciences, Jeff is an angel investor with Techammer and is a board member at Ciox and Cytel. Jeff has a bachelor's degree in Mathematics from Harvard University.

Experienced product focused software executive working with high-growth enterprises to deliver complex and mission critical solutions that provide high-impact to individuals and organizations.

Other Seats

Ciox Health

Ciox Health, and Ciox Health

Ciox Health

Ciox Health

CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo

Compare Ciox Health to Competitors

MRO Logo
MRO

MRO is a provider in disclosure management solutions for healthcare organizations and offers electronic release-of-information (ROI), audit tracking, accounting of disclosures (AOD) and document management software and services. The company's disclosure management solutions can be deployed as a common tracking platform across the healthcare entity, from HIM, radiology and the business office to outpatient clinics and other departments. It was founded in 2013 and is based in Norristown, Pennsylvania.

C
Chart Request

Chart Request is a medical software company that operates in the health information exchange industry. The company's main services include providing a platform for healthcare providers to electronically request, receive, and send health information in a secure, efficient, and HIPAA-compliant manner. The platform also offers features for care coordination, referral management, and record retrieval. The company serves providers, requesters and patients. It was founded in 2012 and is based in Atlanta, Georgia.

Redox Logo
Redox

Redox offers an application program interface technology. It provides a modern application programming interface (API) for healthcare, allowing software to easily and securely interoperate with electronic health records (EHRs) in a health system infrastructure. The company offers various products such as Nova which has real-time data in the cloud, Chroma which patient identity records, and more. It was founded in 2014 and is based in Madison, Wisconsin.

Apixio Logo
Apixio

Apixio focuses on healthcare artificial intelligence (AI) solutions, operating within the healthcare and technology sectors. The company offers a range of services including risk adjustment, clinical guidance, payment integrity, health data management, and utilization management, all powered by artificial intelligence. These services aim to improve administrative, clinical, and financial outcomes by delivering actionable insights from healthcare data. Apixio primarily serves health plans, providers, and Accountable Care Organizations (ACOs). It was founded in 2009 and is based in San Mateo, California.

PocketHealth Logo
PocketHealth

PocketHealth is a company focused on healthcare technology. It offers a platform that allows patients to access, understand, and share their medical records and imaging, as well as store all their important health information in one place. The company primarily serves patients and healthcare providers. PocketHealth was formerly known as PocketSix Technology. It was founded in 2016 and is based in Toronto, Ontario.

Lightbeam Health Solutions Logo
Lightbeam Health Solutions

Lightbeam Health Solutions is a company focused on managing patient populations and associated risk in the healthcare industry. The company offers a population health management platform that transforms disparate healthcare data into a comprehensive view of a patient's health. This platform is primarily used by accountable care organizations, payers, provider groups, and health systems. It is based in Irving, Texas.

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.